Evidence map›Paper›PMID 27562771›Full record

ArticleJournal of neural transmission (Vienna, Austria : 1996)2016

Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.

Johannes Levin, Sylvia Maaß, Madeleine Schuberth, Gesine Respondek, Friedemann Paul, Ullrich Mansmann, Wolfgang H Oertel, Stefan Lorenzl, Florian Krismer, Klaus Seppi and 21 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Journal of neural transmission (Vienna, Austria : 1996), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors.

Johannes LevinDepartment of Neurology, Klinikum Großhadern, Ludwig-Maximilians-Universität, Munich, Germany. jlevin@med.uni-muenchen.de.
Sylvia MaaßGerman Centre for Neurodegenerative Diseases (DZNE), Feodor-Lynen Str. 17, 81377, Munich, Germany.
Madeleine SchuberthDepartment of Neurology, Klinikum Großhadern, Ludwig-Maximilians-Universität, Munich, Germany.
Gesine RespondekGerman Centre for Neurodegenerative Diseases (DZNE), Feodor-Lynen Str. 17, 81377, Munich, Germany.
Friedemann PaulNeuroCure Clinical Research Center and Clinical and Experimental Multiple Sclerosis Research Center, Department of Neurology, Charité University Medicine Berlin, Berlin, Germany.
Ullrich MansmannInstitute for Medical Informatics, Biometry and Epidemiology (IBE), Ludwig-Maximilians-Universität, Munich, Germany.
Wolfgang H OertelDepartment of Neurology, Philipps Universität, Marburg, Germany.
Stefan LorenzlDepartment of Neurology, Klinikum Großhadern, Ludwig-Maximilians-Universität, Munich, Germany.
Florian KrismerDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Klaus SeppiDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Werner PoeweDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Gregor WenningDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
D BergDepartment of Neurodegeneration, Center of Neurology, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Joseph ClaßenDepartment of Neurology, University of Leipzig, Leipzig, Germany.
Georg EbersbachMovement Disorders Clinic, Beelitz-Heilstätten, Germany.
Karla EggertUniversitätsklinikum Giessen und Marburg, Klinik für Neurologie, Marburg, Germany.
Jan KassubekDepartment of Neurology, University of Ulm, Ulm, Germany.
Axel LippDepartment of Neurology, Charité-University Medicine Berlin, Berlin, Germany.
Matthias LöhleDepartment of Neurology, Technische Universität Dresden, Dresden, Germany.
Brit MollenhauerParacelsus-Elena-Klinik, Kasel, Germany.
Alexander MünchauDepartment of Pediatric and Adult Movement Disorders and Neuropsychiatry, Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
Martin SüdmeyerInstitute of Clinical Neuroscience and Medical Psychology, Heinrich-Heine-University, Medical Faculty, Düsseldorf, Germany.
C BlankensteinMünchner Studienzentrum (MSZ), Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
C EberhardtPharmacy, Charité-University Medicine Berlin, Berlin, Germany.
B Ertl-WagnerInstitute for Clinical Radiology, Ludwig-Maximilians-University Munich, Munich, Germany.
H HeiseClinical Study Center, Ludwig-Maximilians-Universität München, Munich, Germany.
I RicardInstitute of Medical Informatics, Biometry, and Epidemiology, University of Munich, Munich, Germany.
PROMESA study group
Armin GieseCenter for Neuropathology and Prion Research, Ludwig-Maximilians-Universität, Munich, Germany.
Kai BötzelDepartment of Neurology, Klinikum Großhadern, Ludwig-Maximilians-Universität, Munich, Germany.
Günter HöglingerGerman Centre for Neurodegenerative Diseases (DZNE), Feodor-Lynen Str. 17, 81377, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27562771

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.